Dr. Brian Ghezelaiagh, MD

Dr. Ghezelaiagh practices at New York Medical Behavioral Health Services in New York, New York.

Dr. Ghezelaiagh's NPI, 1033616206, was assigned on April 12, 2018. Dr. Ghezelaiagh graduated from State University of New York Downstate Medical Center College of Medicine in 2018. Dr. Ghezelaiagh holds New York license 312913.

Dr. Ghezelaiagh's primary practice is New York Medical Behavioral Health Services, at 3 E 83rd St, New York, NY 10028 in New York County. The practice phone is (646) 453-6777.

Dr. Ghezelaiagh's primary practice is New York Medical Behavioral Health Services in New York, New York. The medical group on file is New York Medical Behavioral Health Services. Dmand AI also links Dr. Ghezelaiagh to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ghezelaiagh practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Ghezelaiagh's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Ghezelaiagh is licensed in New York.

CMS data shows 100 Medicare services from Dr. Ghezelaiagh across 3 procedure codes in 2024, for 18 Medicare patients. Medicare paid $10,849 for them. Every service was in an office.

CMS counts 18 Medicare patients who saw Dr. Ghezelaiagh in 2024. The largest group is 85 and over, with 0 patients. 75% of them have anxiety, and 75% have high blood pressure. Their average risk score is 0.76, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ghezelaiagh's median patient age at 29, with 55% women.

In 2024, Dr. Ghezelaiagh wrote 109 Medicare Part D claims for 13 patients. 94% of them were for generic drugs. CMS names the drug for 64 of them, across 5 drugs with 11 or more claims each, at $717 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

Dr. Ghezelaiagh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ghezelaiagh as offering telehealth.

Dmand AI links 3 papers to Dr. Ghezelaiagh, published from 2017 to 2020. The most frequent topics are Schizophrenia. Dr. Ghezelaiagh's most frequent co-authors are Michael Marion Reinhardt, MD, Aninditha Soman Vengassery, MD and Dina Ghoneim, MD.

CMS Open Payments shows 78 general payments to Dr. Ghezelaiagh from 10 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 79% of the total. Neuronetics, Inc. paid the most, $1,060.

Dr. Ghezelaiagh graduated from State University of New York Downstate Medical Center College of Medicine in 2018.